Clinical trial Recruiting at 2 sites Interventional Ages 18 to 80

Rehabilitation methods for stroke patients with unilateral spatial neglect

Official title: A Comparative Analysis of Methods for Rehabilitation of Unilateral Spatial Neglect (USN) in Stroke Patients: Conventional Therapy, Computerized Cognitive Training and Eye Movement Biofeedback Training

Run by Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health · NCT06802159 · Data updated 2026-11-12

This study is testing new ways to help stroke patients with unilateral spatial neglect improve their recovery by combining different types of therapy.

More Unilateral Spatial Neglect (USN) trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment30 (estimated)
SponsorFederal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Academic / other
Locations2 sites (Moscow, Moscow and 1 other locations)
StatusRecruiting
StartedJanuary 9, 2025
Main results expectedJune 15, 2025
Study endsDecember 15, 2025
Registry record updatedJune 22, 2025
Trial IDNCT06802159 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are stroke patients diagnosed with unilateral spatial neglect and who have normal cognitive development according to their age and educational level.

Probably not a fit

Patients with severe mental or somatic pathology, gross oculomotor disorders, or significant sensory visual defects may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on improving rehabilitation methods for stroke patients suffering from unilateral spatial neglect (USN), a condition that complicates recovery and affects functional outcomes. It employs a combination of conventional therapy, eye-tracking based therapy, and cognitive therapy to enhance treatment efficacy. The study aims to assess the effectiveness of these combined approaches in addressing the cognitive and perceptual deficits associated with USN. By targeting both acute and chronic phases of stroke recovery, the study seeks to provide a comprehensive rehabilitation strategy for affected patients.

Why it matters

Potential benefit: If successful, this study could significantly improve rehabilitation outcomes for stroke patients with unilateral spatial neglect, enhancing their functional independence.

How similar studies have gone: Other studies have shown that combined rehabilitation methods can improve outcomes for patients with similar conditions, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Normal cognitive development in accordance with age and educational level;
* diagnosis with codes I63, I61 (ICD);
* presence of unilateral spatial neglect syndrome in the neuropsychological status.

Exclusion Criteria:

* presence of mental and somatic pathology of severe degree and in decompensation stage;
* the presence of gross oculomotor disorders;
* presence of a sensory visual defect of moderate to severe severity

Where it's running

  • Federal Center of Brain and Neurotechnologies of the FMBA of Russia
    Moscow, Moscow, Russia
    Recruiting
  • Federal Center of Brain and Neurotechnologies of the FMBA of Russia
    Moscow, Russia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.